Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review.
By S. Rajagopalan, Sadeer G. Al-Kindi, R. Brook. Journal of the American College of Cardiology, 2018
1,041 citations recorded by the source corpus.
Fine particulate matter <2.5 μm (PM2.5) air pollution is the most important environmental risk factor contributing to global cardiovascular (CV) mortality and disability. Short-term elevations in PM2.5 increase the relative risk of acute CV events by 1% to 3% within a few days. Longer-term exposures over several years increase this risk by a larger magnitude (∼10%), which is partially attributable to the development of cardiometabolic conditions (e.g., hypertension and diabetes mellitus). As such, ambient PM2.5 poses a major threat to global public health. In this review, the authors provide an overview of air pollution and health, including assessment of exposure, impact on CV outcomes, mechanistic underpinnings, and impact of air pollution reduction strategies to mitigate CV risk. The review concludes with future challenges, including the inextricable link between air pollution and climate change, and calls for large-scale trials to allow the promulgation of formal evidence-based recommendations to lower air pollution-induced health risks.
Subfields: Health, Toxicology and Mutagenesis, Pollution
View Paper: https://www.semanticscholar.org/paper/f564879a90df155e7d5bca213f26ca7aa7c307eb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Health, Toxicology and Mutagenesis
Citations in the corpus
- Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions (2019, background): “5 is associated with a significantly enhanced risk for hospitalizations and heart failure mortality.(21) There is ample evidence of adverse health effects from PM2.”